Bio21 welcomes new Incubator Company tenants Patrys Ltd
1 Jan 08
Patrys Limited is an Australian public company (ASX:PAB) committed to the development of natural human antibody based therapies for the treatment of cancer and other major diseases. The team has recently taken up tenancy in the Bio21 Institute's business incubator.
The Company's products derive from a proprietary platform technology that allows for the effective capture, development and production of human antibodies. Patrys' commercial strategy is to leverage its deep pipeline by combining the internal development of lead product candidates with collaborations with larger industry partners aimed at developing additional product candidates. Contact Barbara Power or Vic Ilag for further information (bpower@patrys.com or vilag@patrys.com )
Further information, visit the Patrys website at http://www.patrys.com/
